Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

GSK

since

auto-detected in 23 stories

2 days ago

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

GSK has revealed positive results for a treatment for gynaecological cancers as its chief executiv…

48 days ago

New chief Luke Miels swoops on Canada’s 35Pharma in push to replenish pipeline and boost revenues

69 days ago

New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential

It’s a miracle. A mere 25 years after Glaxo Wellcome and SmithKline Beecham merg…

4 months ago

Emma Walmsley’s praise for US pharmaceutical market piles pressure on the UK government

  • Business live – live updates

The chief executive of GSK yesterday declared the US to be the best place for pharma…

In an interview with the BBC, Dame Emma Walmsley says she will not "shy away" from GSK's US expansion.

6 months ago

The U.K.'s FTSE 100 led gains on Monday.
GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday.

Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live

Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.

  • GSK’s Emma Walmsley to be replaced as chief executive

  • I…

Britain's leading-edge big pharma companies AstraZeneca and GSK are pledging £59billion of investment in the US over the next five years. Spending in Blighty is on hold.

page 1 of 3 last →|